APPLICATION OF MULTIPLEX PCR FOR ANALYSIS OF POLYCOMPONENT PROBIOTIC PREPARATIONS
- Authors: Vainshtok I.I1, Schit I.Y.2, Bondarenko V.M3, Brodsky I.B1
-
Affiliations:
- Partner Closed Joint-Stock Company, Moscow, Russia
- State Scientific Centre of Applied Microbiology and Biotechnology, Obolensk, Russia
- Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia
- Issue: Vol 90, No 5 (2013)
- Pages: 92-96
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.10.2013
- URL: https://microbiol.crie.ru/jour/article/view/13879
- ID: 13879
Cite item
Full Text
Abstract
Aim. Development of multiplex PCR for indication and differential analysis of CFU in a probiotic preparation containing 3 various species of bifidobacteria (Bifidobacterium bifidum, B. longum, B. adolescentis) and 2 species of lactobacilli (Lactobacillus acidophilus, L. plantarum). Materials and methods. Multiplex PCR with primers to 16S RNA genes of 5 species of bacteria was applied. Samples of bacterial colonies were removed from solid nutrient medium and transferred into test-tube for multiplex PCR execution. Bacterial lysates were used as target-matrix for amplification and determination of presence of the required amplicons. Results. Multiplex PCR for detection of CFU of each of the bifidobacteria and lactobacilli strains in samples of 5-component probiotic with accuracy up to species was developed. A reagent kit was fine-tuned and high reproducibility and specificity of the multiplex PCR method with the accuracy of 90-95% of cases was shown. Conclusion. The multiplex PCR method developed is recommended to be applied for CFU control of each bacterial component in a complex probiotic preparation.
About the authors
I. I Vainshtok
Partner Closed Joint-Stock Company, Moscow, Russia
I. Yu Schit
State Scientific Centre of Applied Microbiology and Biotechnology, Obolensk, Russia
V. M Bondarenko
Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia
I. B Brodsky
Partner Closed Joint-Stock Company, Moscow, Russia
References
- Бондаренко В.М. Поликомпонентные пробиотики: механизм действия и терапевтический эффект при дисбиозах кишечника. Фарматека. 2005, 20: 46-54.
- Бондаренко В.М. Обоснование и тактика назначения в медицинской практике различных форм пробиотических препаратов. Фарматека. 2012, 11: 89-99.
- Бондаренко В.М., Мацулевич Т.В. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. ГЭОТАР-медиа. М., 2007.
- Falagas M.E., Betsi G.I., Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: A review. J. Antimicrob. Chemother. 2006, 58: 266-272.
- FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Basel, Switzerland, WHO, 2001.
- Kwon H.S., Yang E.H., Yeon S.W, Kang B.H., Kim T.Y. Rapid identification of probiotic Lactobacillus species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA. FEMS Microbiol. Let. 2004, 239: 267-275.
- Kwon H.S., Yang E.H., Yeon S.W, Kang B.H., Kim T.Y Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol. Let. 2005, 250: 55-62.
- Logan A.C., Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med. Hypotheses. 2005, 64 (3): 533-538.
- Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 1999, 65: 4506-4512.
- Matsuki T., Watanabe K., Tanaka R. Genus- and species-specific PCR primers for the detection and identification of bifidobacteria. Curr. Issues Intest. Microbiol. 2003, 4: 61-69.
- Mitsuoka T. Bifidobacteria and their role in human health. J. Indust. Microbiol. 1990, 6: 263268.
- Preidis G.A., Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics. Gastroenterology enters the metagenomics era. Gastroenterology. 2009, 136: 20152031.
- Reiff C., Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int. J. Med. Microbiol. 2010, 300: 25-33.
- Song Y.L., Kato N., Liu C.X., Matsumiya Y., Kato H., Watanabe K. Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA. FEMS Microbiol.Let. 2000, 187: 167-173.
- Walter J., Tannock G. W., Tilsala-Timisjarvi A., Rodtong S., Loach D., Munro M., Alatossava K. T. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol. 2000, 66 (1): 297303.